Implications for prenatal genetic testing after reversal of Roe v. Wade in the United States
American Journal of Obstetrics and Gynecology(2023)
摘要
Prenatal genetic screening and diagnostic testing should be offered in every pregnancy as a standard of care in the United States. This testing is important for patients who choose to continue their pregnancies, but it is also common for patients to choose termination after a positive result. Options for diagnostic testing vary by gestational age, with chorionic villus sampling (CVS) offered at an earlier gestational age (10-13 weeks) than amniocentesis (15 weeks gestation). Our objective was to determine the effect of new gestational age-based abortion restrictions on options for feasible genetic diagnostic testing by state.
更多查看译文
关键词
prenatal genetic testing,roe,reversal
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要